|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sherman M: Hepatocellular carcinoma:
Epidemiology, surveillance, and diagnosis. Semin Liver Dis.
30:3–16. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Geng M, Xin X, Bi LQ, Zhou LT and Liu XH:
Molecular mechanism of hepatitis B virus X protein function in
hepatocar-cinogenesis. World J Gastroenterol. 21:10732–10738. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang T, Zhang J, You X, Liu Q, Du Y, Gao
Y, Shan C, Kong G, Wang Y, Yang X, et al: Hepatitis B virus X
protein modulates oncogene Yes-associated protein by CREB to
promote growth of hepatoma cells. Hepatology. 56:2051–2059. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xu C, Zhou W, Wang Y and Qiao L: Hepatitis
B virus-induced hepatocellular carcinoma. Cancer Lett. 345:216–222.
2014. View Article : Google Scholar
|
|
7
|
Levrero M and Zucman-Rossi J: Mechanisms
of HBV-induced hepatocellular carcinoma. J Hepatol. 64(Suppl):
S84–S101. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Artavanis-Tsakonas S, Rand MD and Lake RJ:
Notch signaling: Cell fate control and signal integration in
development. Science. 284:770–776. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Miele L, Golde T and Osborne B: Notch
signaling in cancer. Curr Mol Med. 6:905–918. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rizzo P, Osipo C, Foreman K, Golde T,
Osborne B and Miele L: Rational targeting of Notch signaling in
cancer. Oncogene. 27:5124–5131. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Geisler F and Strazzabosco M: Emerging
roles of Notch signaling in liver disease. Hepatology. 61:382–392.
2015. View Article : Google Scholar
|
|
12
|
Wang F, Zhou H, Xia X, Sun Q, Wang Y and
Cheng B: Activated Notch signaling is required for hepatitis B
virus X protein to promote proliferation and survival of human
hepatic cells. Cancer Lett. 298:64–73. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang F, Zhou H, Yang Y, Xia X, Sun Q, Luo
J and Cheng B: Hepatitis B virus X protein promotes the growth of
hepatocel-lular carcinoma by modulation of the Notch signaling
pathway. Oncol Rep. 27:1170–1176. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gao J, Xiong Y, Wang Y, Wang Y, Zheng G
and Xu H: Hepatitis B virus X protein activates Notch signaling by
its effects on Notch1 and Notch4 in human hepatocellular carcinoma.
Int J Oncol. 48:329–337. 2016. View Article : Google Scholar
|
|
15
|
Kongkavitoon P, Tangkijvanich P, Hirankarn
N and Palaga T: Hepatitis B virus HBx activates Notch signaling via
delta-like 4/Notch1 in hepatocellular carcinoma. PLoS One.
11:e01466962016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ding ZY, Jin GN, Wang W, Chen WX, Wu YH,
Ai X, Chen L, Zhang WG, Liang HF, Laurence A, et al: Reduced
expression of transcriptional intermediary factor 1 gamma promotes
metastasis and indicates poor prognosis of hepatocellular
carcinoma. Hepatology. 60:1620–1636. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen L, Zhang W, Zhou QD, Yang HQ, Liang
HF, Zhang BX, Long X and Chen XP: HSCs play a distinct role in
different phases of oval cell-mediated liver regeneration. Cell
Biochem Funct. 30:588–596. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xiang S, Dong HH, Liang HF, He SQ, Zhang
W, Li CH, Zhang BX, Zhang BH, Jing K, Tomlinson S, et al: Oval cell
response is attenuated by depletion of liver resident macrophages
in the 2-AAF/partial hepatectomy rat. PLoS One. 7:e351802012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dong HH, Xiang S, Chen XP, Liang HF, Zhang
W, Jing K, Zhang W, Zhang WG and Chen L: The epithelial-mesenchymal
transition promotes transdifferentiation of subcutaneously
implanted hepatic oval cells into mesenchymal tumor tissue. Stem
Cells Dev. 18:1293–1298. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen L, Zhang W, Liang HF, Zhou QF, Ding
ZY, Yang HQ, Liu WB, Wu YH, Man Q, Zhang BX, et al: Activin A
induces growth arrest through a SMAD-dependent pathway in hepatic
progenitor cells. Cell Commun Signal. 12:182014. View Article : Google Scholar
|
|
21
|
Maraver A, Fernandez-Marcos PJ, Herranz D,
Cañamero M, Muñoz-Martin M, Gómez-López G, Mulero F, Megías D,
Sanchez-Carbayo M, Shen J, et al: Therapeutic effect of γ-secretase
inhibition in KrasG12V-driven non-small cell lung carcinoma by
derepression of DUSP1 and inhibition of ERK. Cancer Cell.
22:222–234. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Calvisi DF, Pinna F, Meloni F, Ladu S,
Pellegrino R, Sini M, Daino L, Simile MM, De Miglio MR, Virdis P,
et al: Dual-specificity phosphatase 1 ubiquitination in
extracellular signal-regulated kinase-mediated control of growth in
human hepatocellular carcinoma. Cancer Res. 68:4192–4200. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen X, Song M, Chen W,
Dimitrova-Shumkovska J, Zhao Y, Cao Y, Song Y, Yang W, Wang F,
Xiang Y, et al: MicroRNA-21 Contributes to Liver Regeneration by
Targeting PTEN. Med Sci Monit. 22:83–91. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liao B, Liang H, Chen J, Liu Q, Zhang B
and Chen X: Suberoylanilide hydroxamic acid enhances
chemosensitivity to 5-fluorouracil in hepatocellular carcinoma via
inhibition of thymidylate synthase. Tumour Biol. 36:9347–9356.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ding ZY, Jin GN, Liang HF, Wang W, Chen
WX, Datta PK, Zhang MZ, Zhang B and Chen XP: Transforming growth
factor β induces expression of connective tissue growth factor in
hepatic progenitor cells through Smad independent signaling. Cell
Signal. 25:1981–1992. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tchen CR, Martins JR, Paktiawal N, Perelli
R, Saklatvala J and Clark AR: Glucocorticoid regulation of mouse
and human dual specificity phosphatase 1 (DUSP1) genes: Unusual
cis-acting elements and unexpected evolutionary divergence. J Biol
Chem. 285:2642–2652. 2010. View Article : Google Scholar :
|
|
27
|
Real PJ, Tosello V, Palomero T, Castillo
M, Hernando E, de Stanchina E, Sulis ML, Barnes K, Sawai C,
Homminga I, et al: Gamma-secretase inhibitors reverse
glucocorticoid resistance in T cell acute lymphoblastic leukemia.
Nat Med. 15:50–58. 2009. View
Article : Google Scholar
|
|
28
|
Palomero T, Sulis ML, Cortina M, Real PJ,
Barnes K, Ciofani M, Caparros E, Buteau J, Brown K, Perkins SL, et
al: Mutational loss of PTEN induces resistance to NOTCH1 inhibition
in T-cell leukemia. Nat Med. 13:1203–1210. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ding ZY, Liang HF, Jin GN, Chen WX, Wang
W, Datta PK, Zhang MZ, Zhang B and Chen XP: Smad6 suppresses the
growth and self-renewal of hepatic progenitor cells. J Cell
Physiol. 229:651–660. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Iso T, Kedes L and Hamamori Y: HES and
HERP families: Multiple effectors of the Notch signaling pathway. J
Cell Physiol. 194:237–255. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sang L, Roberts JM and Coller HA:
Hijacking HES1: How tumors co-opt the anti-differentiation
strategies of quiescent cells. Trends Mol Med. 16:17–26. 2010.
View Article : Google Scholar
|
